Saturday, February 18, 2023 11:19:40 AM
The biggest issue is what has always been the case and that is the ability to fund any meaningful clinical trials should he get FDA IND approval to start.
He has already failed once with HemaX. And he'll fail again because NO LEGIT Biotech or BP funds IP of a small, one man run, dysfunctional OTC biotech.
Why do you think that no one to date has partnered with Regen to fund their IP?
Many threw their money away and bought into the false hype of a pinky stinky scam stock.
All the warning signs were there. Heck, I personally pointed people to the info yet when one has $$$$ in their eyes thinking of the quick score, one ignores facts and reality.
FACTS are stubborn things
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM